Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts.
Now here’s the best of what YOU had to say:
- Wikileaks in the Electronic Medical Record Era. “No matter what people think of Wikileaks disclosure of approximately 250,000 classified diplomatic cables to the Internet yesterday with the help of the New York Times, The Guardian, Der Spiegel, and Le Monde, the implications to electronic healthcare information security are significant.”
- ‘Potential troubling gap’ in FDA’s oversight of med device trials. “The Journal, citing the failed clinical trial of an Aptus Endosystems Inc. stent graft, said the lack of oversight means ‘hundreds of participants in clinical-trial studies of medical devices may be at risk of receiving faulty devices.’ “
- A Provenge Medicare payout should add scrutiny. “Can Medicare afford the next generation of marginally effective cancer drugs, whose price tags are approaching $100,000 a year?”
- Drug recalls have hurt confidence in FDA. “The pollsters found that slightly more than half (51 percent) expressed a favorable opinion of the Food & Drug Administration’s performance, but that high-profile drug recalls had damaged confidence in the watchdog agency.”
